Millennium Development Goals on nutrition and health seek to end hunger and significantly reduce malnutrition and premature death by 2025. Health systems and health professionals have important roles in meeting these goals.
AMA J Ethics. 2018;20(10):E979-986. doi:
10.1001/amajethics.2018.979.
Sociocultural and economic factors drive transition from plant-based to animal-based protein sources in rapidly developing and urbanizing countries of South Asia and Southeast Asia. Better understanding the health impact of this transition requires integrating epidemiological and social science research methods.
AMA J Ethics. 2018;20(10):E987-993. doi:
10.1001/amajethics.2018.987.
Efrat Lelkes, MD, Angira Patel, MD, MPH, Anna Joong, MD, and Jeffrey G. Gossett, MD
Current policy requires separate informed consent for some Public Health Service increased-risk donors, and this can make shared decision making harder.
AMA J Ethics. 2020;22(5):E401-407. doi:
10.1001/amajethics.2020.401.
Cynthia E. Schairer, PhD, Caryn Kseniya Rubanovich, MS, and Cinnamon S. Bloss, PhD
Questions about data privacy need to be addressed when research institutions negotiate with companies developing mobile health applications. Commercial terms of use and data sharing notifications should be reviewed before use in human subject research settings.
AMA J Ethics. 2018;20(9):E864-872. doi:
10.1001/amajethics.2018.864.
Bias toward allopathic medicine in the research funding and publication of study results makes it difficult for physicians and others to find accurate data about the efficacy of non-Western, nonallopathic treatments.
Sheldon Zink, PhD, Rachel Zeehandelaar, and Stacey Wertlieb, MBe
The benefits of the international presumed-consent policy are presented as a solution to the United States' current shortage of organs available for transplantation.
The implementation of breakthrough quality improvement initiatives has been successful in closing the gap between the number of organs that are available and the number of patients who need them.
We really can't promise both more transplants and better outcomes. The controversies over organ allocation really represent intellectual exhaustion in the face of a long series of inadequate policy responses to the decade-long trend of the kidney supply increasing only at the expense of organ quality and patient outcomes.